---

---

symbols : Sny    crawled time : 19:00   

save search

---

The Global Probiotics Market Forecasted to Flourish as Wellness Trends Gain Momentum, the Market to Hit $115.07 Billion - Focus Research Report by Arizton
Published: 2024-04-09 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
CVS | $68.945 -0.98% 4M |

Retail Trade

| -5.08% | O: -0.35% H: 0.11% C: -2.67%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -2.64% | O: -0.32% H: 0.0% C: 0.0%
report research global wellness trends market

---

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| Email alert Add to watchlist
PRGO | $30.515 1.51% 490K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

---

Sanofi: Information concerning the total number of voting rights and shares - February 2024
Published: 2024-03-15 (Crawled : 19:00) - globenewswire.com
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
total

---

Biopharma Layoff Tracker 2024: Meissa, Pfizer, Arrakis and More Cut Staff
Published: 2024-03-05 (Crawled : 19:00) - biospace.com/
RLYB | News | $1.84 3.96% 160K |

| -10.15% | O: 4.06% H: 5.36% C: -9.51%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -7.46% | O: -0.3% H: 0.0% C: 0.0%
VXRT | News | $0.7539 -1.13% 820K |

Health Technology

| -37.96% | O: -0.41% H: 1.64% C: -0.82%
TXMD | News | $1.875 -0.27% 13K |

Health Technology

| -28.65% | O: 0.19% H: 3.03% C: 1.89%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -1.54% | O: 1.17% H: 0.0% C: 0.0%
PTCT | News S | $25.66 -1.19% 220K |

Health Technology

| -16.17% | O: -0.87% H: 2.83% C: 1.92%
NKTR | News | $1.41 3.68% 710K |

Health Technology

| 51.11% | O: -0.93% H: 4.02% C: -0.84%
MOR | News | $17.965 0.03% 150K |

Health Technology

| 1.3% | O: -0.28% H: 0.28% C: 0.0%
GLPG | News | $29.67 2.06% 88K |

Health Technology

| -16.13% | O: 0.17% H: 0.46% C: -0.6%
AMRN | News | $0.8888 2.67% 560K |

Health Technology

| -5.84% | O: -0.81% H: 9.08% C: 2.68%
GOOGL | News S | $158.36 1.33% 13M |

Technology Services

| 17.2% | O: -1.1% H: 1.03% C: 0.6%
GOOG | News S | $159.94 1.26% 9.4M |

Technology Services

| 17.7% | O: -1.09% H: 0.96% C: 0.78%
OCX | News | $2.46 -1.99% 20K |

Health Technology

| -16.33% | O: -1.31% H: 3.02% C: 2.0%
biopharma

---

Biopharma Layoff Tracker 2024: Moderna, Gritstone, Kineta and More Cut Staff
Published: 2024-03-01 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K |

Health Technology

| -2.32% | O: 0.01% H: 0.0% C: -0.43%
RLYB | News | $1.84 3.96% 160K |

| -23.87% | O: 1.08% H: 6.81% C: 0.43%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -7.6% | O: 0.28% H: 0.0% C: 0.0%
VXRT | News | $0.7539 -1.13% 820K |

Health Technology

| -37.7% | O: 2.46% H: 0.8% C: 0.0%
TXMD | News | $1.875 -0.27% 13K |

Health Technology

| -21.67% | O: 0.0% H: 7.92% C: 5.83%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -3.57% | O: -1.27% H: 0.0% C: 0.0%
PTCT | News S | $25.66 -1.19% 220K |

Health Technology

| -7.88% | O: -6.0% H: 24.17% C: 20.57%
NKTR | News | $1.41 3.68% 710K |

Health Technology

| 91.55% | O: 0.7% H: 11.75% C: 9.09%
MOR | News | $17.965 0.03% 150K |

Health Technology

| 2.1% | O: 0.0% H: 0.62% C: 0.57%
GLPG | News | $29.67 2.06% 88K |

Health Technology

| -17.2% | O: -0.09% H: 0.57% C: 0.09%
AMRN | News | $0.8888 2.67% 560K |

Health Technology

| -18.69% | O: -4.67% H: 3.92% C: 3.92%
GOOGL | News S | $158.36 1.33% 13M |

Technology Services

| 12.87% | O: -0.02% H: 0.32% C: -0.93%
GOOG | News S | $159.94 1.26% 9.4M |

Technology Services

| 13.0% | O: -0.12% H: 0.28% C: -1.1%
OCX | News | $2.46 -1.99% 20K |

Health Technology

| -13.75% | O: 2.41% H: 1.51% C: 0.67%
biopharma

---

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -4.29% | O: -0.63% H: 0.0% C: 0.0%
INBX | $34.37 0.79% 94K |

Health Technology

| -13.8% | O: -0.86% H: 0.13% C: -5.66%
year financial results

---

FDA Decisions: CMC Issues Thwart Venatorx and Melinta’s Urinary Tract Infection Antibiotic
Published: 2024-02-23 (Crawled : 19:00) - biospace.com/
PRGO | $30.515 1.51% 490K |

Health Technology

| -5.5% | O: 0.22% H: 0.85% C: 0.85%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -7.06% | O: 0.28% H: 0.0% C: 0.0%
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| -10.04% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -3.42% | O: 0.97% H: 0.0% C: 0.0%
fda infection

---

Viral Vectors and Plasmid DNA Global Market Report 2024 - A 1.66 Billion Market by 2028, Registering a Forecasted 14.8% CAGR
Published: 2024-02-19 (Crawled : 19:00) - prnewswire.com
LZAGF | $541.144 24 |

Health Technology

| 2.68% | O: -1.9% H: 0.0% C: -0.97%
SNYNF | News | $92.7 600K |

Health Technology

| 0.38% | O: 2.72% H: 0.0% C: -0.8%
LZAGY | $55.69 29K |

Professional, Scientific, and T...

| 7.43% | O: -0.12% H: 0.04% C: -0.44%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| 0.1% | O: 2.53% H: 0.0% C: 0.0%
report global dna market

---

Genome Editing Market Report 2024: Technology Licensing Deals are Driving the Overall Partnership Activity - Global Industry Trends and Forecasts 2023-2035
Published: 2024-02-07 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -1.05% | O: -1.64% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -1.86% | O: -2.25% H: 0.0% C: 0.0%
partnership report global trends technology market

---

Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
Published: 2024-01-03 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K |

Health Technology

| -7.3% | O: 0.49% H: 0.0% C: -0.26%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -6.29% | O: 1.38% H: 0.0% C: 0.0%
conference therapeutics

---

Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories
Published: 2023-12-19 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -3.41% | O: -0.39% H: 1.49% C: 0.32%
NVSEF | News | $95.11 490 |

Health Technology

| -1.44% | O: 0.8% H: 0.0% C: 0.0%
NVS | News | $97.25 2.24% 2.6M |

Health Technology

| -3.58% | O: -0.15% H: 0.27% C: -1.02%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -3.98% | O: 0.73% H: 0.0% C: 0.0%
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| -0.92% | O: 0.01% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -4.92% | O: 0.21% H: 0.0% C: 0.0%
disorders treatment pharmaceuticals global market

---

Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $176.0 50 |

n/a

| -2.22% | O: 5.56% H: 0.71% C: 0.71%
CSLLY | $89.17 54K |

n/a

| -2.72% | O: 1.46% H: 3.01% C: 0.97%
GLAXF | News | $20.305 630 |

Health Technology

| 10.81% | O: 0.58% H: 0.0% C: -1.01%
SNYNF | News | $92.7 600K |

Health Technology

| -3.35% | O: 0.25% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 7.33% | O: 1.19% H: 3.09% C: 1.3%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 10.48% | O: 0.76% H: 1.0% C: -0.11%
BAX | $41.01 1.51% 1.1M |

Health Technology

| 7.36% | O: 1.7% H: 2.44% C: 1.78%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -4.19% | O: 0.0% H: 0.0% C: 0.0%
AZN | News | $70.93 1.14% 3.8M |

Health Technology

| 6.42% | O: 1.21% H: 0.27% C: -0.52%
america vaccine influenza growth market

---

Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $95.11 490 |

Health Technology

| Email alert Add to watchlist
BHC | $8.565 1.36% 1.2M |

Health Technology

| Email alert Add to watchlist
BIIB | $193.99 -0.06% 660K |

Health Technology

| Email alert Add to watchlist
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
BCLI A | $0.531 -1.69% 110K |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.355 0.93% 2.3M |

Health Technology

| Email alert Add to watchlist
NVS | News | $97.25 2.24% 2.6M |

Health Technology

| Email alert Add to watchlist
disease companies health therapeutics market

---

Global Beta Blockers Market Set for Robust Growth with a CAGR of 5.19% and Market Value of $11.54 Billion by 2027
Published: 2023-11-22 (Crawled : 19:00) - prnewswire.com
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| Email alert Add to watchlist
LLY | News | $744.47 1.8% 1M |

Health Technology

| Email alert Add to watchlist
global set growth market

---

COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 18.09% | O: 0.41% H: 0.0% C: 0.0%
VTRS | News A | $11.355 0.93% 2.3M |

Health Technology

| 22.15% | O: 0.11% H: 0.33% C: -0.98%
TEVA | $12.955 0.58% 4.6M |

Health Technology

| 42.32% | O: 0.22% H: 1.49% C: -0.33%
TAK | News | $13.41 0.37% 1M |

Health Technology

| -2.55% | O: 0.44% H: 0.22% C: 0.07%
NVS | News | $97.25 2.24% 2.6M |

Health Technology

| 1.41% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -1.68% | O: 0.18% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 16.67% | O: 0.55% H: 0.3% C: 0.0%
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| 12.02% | O: -0.42% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| 1.31% | O: -1.32% H: 0.0% C: 0.0%
covid-19

---

Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published: 2023-10-25 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K |

Health Technology

| -10.43% | O: 0.4% H: 1.29% C: 1.29%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -11.67% | O: 1.43% H: 0.64% C: -0.09%
ALNY | $145.9 0.08% 230K |

Health Technology

| -11.08% | O: -1.28% H: 0.58% C: -1.46%
disease alzheimer’s positive results

---

Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Published: 2023-10-23 (Crawled : 19:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -55.56% | O: -44.44% H: 60.0% C: -20.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 12.11% | O: 1.37% H: 1.36% C: 1.36%
VTRS | News A | $11.355 0.93% 2.3M |

Health Technology

| 26.12% | O: 0.45% H: 2.46% C: 1.67%
NVO | News | $128.15 2.31% 2.6M |

Health Technology

| 28.97% | O: -0.79% H: 1.41% C: 1.21%
LLY | News | $744.47 1.8% 1M |

Health Technology

| 24.83% | O: -0.84% H: 0.0% C: 0.0%
BAX | $41.01 1.51% 1.1M |

Health Technology

| 22.98% | O: 0.2% H: 0.9% C: -1.05%
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| 10.19% | O: -1.82% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -10.99% | O: 0.77% H: 0.0% C: 0.0%
AZN | News | $70.93 1.14% 3.8M |

Health Technology

| 11.23% | O: 0.38% H: 2.31% C: 2.02%
report business global growth

---

Sanofi: Information concerning the total number of voting rights and shares - September 2023
Published: 2023-10-17 (Crawled : 19:00) - globenewswire.com
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -14.95% | O: -1.23% H: 0.0% C: 0.0%
total

---

Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
Published: 2023-08-03 (Crawled : 19:00) - globenewswire.com
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -7.76% | O: 2.43% H: 0.0% C: 0.0%
disease rsv

---

Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published: 2023-07-28 (Crawled : 19:00) - prnewswire.com
TRUMY | $16.94 52K |

Manufacturing

| Email alert Add to watchlist
NVO | News | $128.15 2.31% 2.6M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
LLY | News | $744.47 1.8% 1M |

Health Technology

| Email alert Add to watchlist
TRUMF | $16.488 1.7K |

Health Technology

| Email alert Add to watchlist
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
reach global insulin market

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.56 162.07% 21M |

AGBA | $2.74 119.2% 52M |

Finance

CZOO | $9.07 81.76% 22M |

EDBL | News | $6.56 74.47% 1.8M |

MTC | $2.21 41.67% 5.6M |

Technology Services

OPRT | News | $3.12 38.67% 11M |

Finance

PALI | $6.59 33.67% 23M |

Manufacturing

VNRX | $0.7945 32.42% 3.1M |

Health Technology

MLEC | $1.81 29.29% 2.8M |

n/a

BTCM | $3.45 27.78% 640K |

Arts, Entertainment, and Recrea...

---

Your saved searches

---